Home LiteratureArticle Details
PMID: 6553517 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Characterization of tumor-associated lymphocytes in a series of mouse mammary tumor lines with differing biological properties.

Cancer immunology, immunotherapy : CII ·Vol. 15 ·No. 2 ·1983-00-00 ·Pages 87-91

Rios AM, Miller FR, Heppner GH

Abstract

Tumor-associated lymphocytes were isolated by isokinetic gradient separation from five related mouse mammary tumor lines with different immunological and growth characteristics. Although considerable variation in recovery rates was seen from experiment to experiment, the five tumor types were found to have reproducible and characteristic patterns of T lymphocyte subpopulations, as detected by cytotoxicity assay using monoclonal antisera to Thy-1, Lyt-1, and Lyt-2 antigens. Tumors of line 168, which are weakly immunogenic at best, had the lowest numbers of recovered ALS+, Thy1+ lymphocytes (12% and 9%, respectively), in contrast to immunogenic lines (mean 38% and 26%, respectively). Line 68H tumors, which grow after prolonged latency periods and also produce tumor cell variants in vivo, were unique in that the numbers of recovered Lyt 1+ lymphocytes exceeded the number of Lyt 2+ lymphocytes, whereas these two T cell subpopulations were either equal or Lyt 2+ cells predominated in the other faster growing, non-variant-producing tumors. No differences in T lymphocyte distribution were associated with the presence or absence of metastatic behavior. These results indicate that distinctive lymphocyte infiltrates may be characteristic of tumors with distinct biological differences.

MeSH Terms
Animals Cell Line Cell Separation Centrifugation, Density Gradient/methods Cytotoxicity, Immunologic Immune Sera Lymphocytes/cytology,immunology Male Mammary Neoplasms, Experimental/immunology,pathology Mice Mice, Inbred Strains
Chemicals
Immune Sera
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rios A M
Miller F R
Heppner G H
References (13)
13 references, click to expand
  1. In situ lymphoid cells of mouse mammary tumors. I. Development and evaluation of a method for the separation of lymphoid cells from mouse mammary tumors.
    J Immunol. 1978 Jun;120(6):1876-80 PMID: 659881
  2. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
    Cancer Res. 1978 Nov;38(11 Pt 1):3758-63 PMID: 698935
  3. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Cancer Res. 1978 Aug;38(8):2492-500 PMID: 667845
  4. Heterogeneity of tumor cells from a single mouse mammary tumor.
    Cancer Res. 1978 Oct;38(10):3174-81 PMID: 210930
  5. In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors.
    J Immunol. 1978 Jun;120(6):1887-91 PMID: 659883
  6. Humoral thymic factors influencing postthymic cells.
    Ann N Y Acad Sci. 1975 Feb 28;249:89-105 PMID: 236722
  7. Activity of lymphoid cells separated from mammary tumors in blastogenesis and Winn assays.
    J Natl Cancer Inst. 1980 Aug;65(2):405-10 PMID: 6931258
  8. Postthymic precursor cells give rise to both Lyt-1 and Lyt-23 subsets of T cells.
    Transplant Proc. 1979 Mar;11(1):907-9 PMID: 313111
  9. Estimation of experimental conditions that permit cell separations by velocity sedimentation on isokinetic gradients of Ficoll in tissue culture medium.
    Anal Biochem. 1971 May;41(1):248-55 PMID: 5578543
  10. In situ lymphoid cells of mouse mammary tumors. II. The characterization of lymphoid cells separated from mouse mammary tumors.
    J Immunol. 1978 Jun;120(6):1881-6 PMID: 659882
  11. Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor.
    Cancer Res. 1980 Nov;40(11):3977-81 PMID: 7471048
  12. Production of T-cell lines with inhibitory or stimulatory activity against syngeneic tumors in vivo. A preliminary report.
    Int J Cancer. 1981 Nov 15;28(5):611-4 PMID: 6796530
  13. Characterization of a variant-producing tumor cell line from a heterogeneous strain BALB/cfC3H mouse mammary tumor.
    Cancer Res. 1981 Apr;41(4):1293-300 PMID: 6260334
Article Info
Journal
Cancer immunology, immunotherapy : CII
Abbr.
Cancer Immunol Immunother
ISSN
0340-7004
Published
1983-00-00
Pages
87-91
Language
English
Region
Germany
NLM ID
8605732
Subset
IM
Grants
NCI NIH HHS · CA-27437 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]